The flu vaccine FluMist, which is made by Gaithersburg-based MedImmune Inc., is at the center of a new debate over vaccinations for the upcoming flu season. In June, a Centers for Disease Control and Prevention advisory committee recommended health providers not use the “nasal spray” flu vaccine produced by MedImmune, a subsidiary of U.K. pharmaceutical giant AstraZeneca PLC (NYSE: AZN). Officials from the CDC cited data showing poor or relatively lower effectiveness of that vaccine, which contains…
from http://www.bizjournals.com/baltimore/news/2016/08/17/questions-raised-about-effectiveness-of.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/149075692872
No comments:
Post a Comment